Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (76)
- Advertising (65)
- COVID-19 vaccines (30)
- Medicine safety (27)
- Regulatory compliance (17)
- Labelling and packaging (8)
- Legislation (8)
- Listed medicines (8)
- Non-prescription medicines (8)
- Prescription medicines (8)
- Therapeutic goods regulation (8)
- Vaping hub (8)
- Assessed listed medicines (6)
- Complementary medicines (4)
- Safety (4)
- Manufacturing (3)
- Medical devices safety (3)
- Medicinal cannabis hub (3)
- Over the counter (OTC) medicines (3)
- Alert/Advisory (2)
- In Vitro Diagnostic medical devices (IVDs) (2)
- Scheduling (national classification system) (2)
- Advisory bodies and committees (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Blood safety (1)
- Compliance and enforcement hub (1)
- Import and export (1)
- Shortages (1)
- Sunscreens (1)
- Travelling with health products (1)
- Weight loss products (1)
Search
209 result(s) found, displaying 101 to 125
-
NoticesThis Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.
-
NoticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.
-
Media releasesThe TGA has commenced court proceedings in the Federal Court of Australia against Prefixx Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesWhen new safety information for medicines is identified, the Therapeutic Goods Administration (TGA) works with the sponsors to update Product Information (PI) to ensure that health professionals and consumers have access to this information.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe transition period from the 2018 to the 2021 Advertising Code ends 30 June 2022.
-
Media releasesThe TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.
-
Media releasesThe TGA has issued four infringement notices totalling $10,664 to an individual for alleged unlawful importation of COVID-19 rapid antigen tests (RATs).
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a NSW based individual for the alleged unlawful advertising of a medicine that was not included in the Australian Register of Therapeutic Goods.
-
Media releasesThe TGA has issued ten infringement notices totalling $133,200 to Philips Electronics Australia Ltd.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued 15 infringement notices totalling $39,960 to a New South Wales based individual for alleged unlawful importation of the prescription-only medicines ivermectin and doxycycline.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has cancelled the listed complementary medicine FatBlaster Max (AUST L 348163) from the Australian Register of Therapeutic Goods (ARTG) for alleged breaches of the Therapeutic Goods Act 1989.
-
Media releasesTMF Cosmeceuticals Pty Ltd fined $26,640 for alleged unlawful importation of ivermectin
-
Media releasesThe TGA has issued three infringement notices totalling $39,960 to New South Wales based company Khazanah Nasional Pty Ltd for alleged unlawful advertising of disposable liquid nicotine vaping products.
-
Media releasesAussiewhip Pty Ltd fined $39,960 for alleged unlawful advertising of disposable nicotine vaping products
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a Sydney based individual for alleged unlawful importation of unregistered anaesthetic products.
-
Media releasesThe TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
-
Media releasesThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsThe Prescribing Medicines in Pregnancy database has now been updated.
-
Media releasesFuturePro was convicted and released on recognisance, its directior was convicted and fined $25,000.